daunorubicin has been researched along with sodium azide in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 10 (58.82) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbieri, KP; Carlos, IZ; Chelucci, RC; Chung, MC; de Faria Fernandes Belone, A; de Melo, TR; Diório, SM; do Nascimento, DC; dos Santos, JL; Placeres, MC; Rosa, PS; Yamasaki, PR | 1 |
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Daniel, JC; Lecerf, JM; Levy, SB; Slapak, CA | 1 |
Bouchelouche, P; Friche, E; Jensen, PB; Sehested, M; Skovsgaard, T | 1 |
Mersch-Sundermann, V | 1 |
Gollapudi, S; Gupta, S | 1 |
Baker, MA; Bhalla, K; Gervasoni, JE; Hindenburg, AA; Krishna, S; Lutzky, J; Rosado, M; Stewart, VJ; Taub, RN | 1 |
Ahmed, NK; Vasanthakumar, G | 1 |
Bolard, J; Henry, N | 1 |
Du Vall, EM; Murray, SL; Slater, LM | 1 |
Gasiorowski, K; Szyba, K; Urban, J | 1 |
Maare, C; Nielsen, D; Skovsgaard, T | 1 |
Collins, PW; Jiang, XR; Macey, MG; Newland, AC | 1 |
Levy, SB; Martell, RL; Slapak, CA; Terashima, M | 1 |
Fujita, T; Fukuzumi, M; Muranishi, S; Nishimaki, A; Yamada, H; Yamamoto, A | 1 |
Bailly, JD; Bousquet, C; Demur, C; Herbert, JM; Laurent, G; Lautier, D | 1 |
Gruber, A; Knaust, E; Peterson, C; Porwit-MacDonald, A; Xu, D | 1 |
17 other study(ies) available for daunorubicin and sodium azide
Article | Year |
---|---|
Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Dapsone; Dose-Response Relationship, Drug; Humans; Leprosy; Mice; Mice, Nude; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium leprae; Structure-Activity Relationship; Thalidomide | 2014 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Compartmentation; Chloroquine; Daunorubicin; Deoxyglucose; Dinitrophenols; Drug Interactions; Drug Resistance; Energy Metabolism; Ethylmaleimide; Humans; Leukemia; Membrane Glycoproteins; Methylamines; Microscopy, Fluorescence; Monensin; Ouabain; Sodium Azide; Tumor Cells, Cultured; Vanadates; Verapamil | 1992 |
Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changes.
Topics: Animals; Azides; Calcium; Calcium-Binding Proteins; Carcinoma, Ehrlich Tumor; Cell Survival; Daunorubicin; Drug Interactions; Drug Resistance; Egtazic Acid; Ionomycin; Mice; Sodium Azide; Tumor Cells, Cultured; Vincristine | 1991 |
The SOS-Chromo-spottest: evaluation of a short-term test for the determination of genotoxic compounds in contaminated environmental samples.
Topics: 4-Nitroquinoline-1-oxide; Azides; Culture Media; Daunorubicin; Environmental Pollution; Escherichia coli; Fluorenes; Methyl Methanesulfonate; Mutagens; Predictive Value of Tests; Sodium Azide; SOS Response, Genetics | 1991 |
Human immunodeficiency virus I-induced expression of P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Cell Line; Cell Transformation, Viral; Cyclosporins; Daunorubicin; Drug Resistance; Flow Cytometry; HIV-1; Humans; Membrane Glycoproteins; Membrane Potentials; Sodium Azide; Zidovudine | 1990 |
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
Topics: Antibiotics, Antineoplastic; Azides; Cell Line; Cell Nucleus; Cytoplasm; Daunorubicin; Deoxyglucose; Drug Resistance; Fluorescence; Golgi Apparatus; Leukemia, Myeloid; Mitochondria; Protons; Sodium Azide; Temperature | 1989 |
Comparative uptake, retention and cytotoxicity of daunorubicin by human myeloid cells.
Topics: Azides; Cell Line; Chromatography, High Pressure Liquid; Daunorubicin; Glucose; Humans; Hydrogen-Ion Concentration; Kinetics; Leukemia, Myeloid, Acute; Sodium Azide | 1986 |
Synergistic incorporation of daunorubicin in erythrocytes in the presence of polyene antibiotics. Role of the membrane potential.
Topics: Amphotericin B; Antifungal Agents; Azides; Buffers; Candicidin; Cations; Cell Membrane Permeability; Daunorubicin; Drug Synergism; Erythrocyte Membrane; Humans; Membrane Potentials; Potassium; Sodium Azide; Valinomycin | 1986 |
Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma.
Topics: Animals; Azides; Biological Transport, Active; Calcium; Carcinoma, Ehrlich Tumor; Daunorubicin; Drug Resistance; In Vitro Techniques; Mice; Mice, Inbred BALB C; Sodium Azide | 1984 |
Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Aminacrine; Antimutagenic Agents; Azides; Benzo(a)pyrene; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Methyl Methanesulfonate; Methylcholanthrene; Microsomes, Liver; Mitomycin; Mutagenicity Tests; Mutagens; Salmonella typhimurium; Sodium Azide; Todralazine | 1994 |
Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Carcinoma, Ehrlich Tumor; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Gene Expression Regulation; Glucose; Male; Mice; Mice, Inbred DBA; Sodium Azide; Tumor Cells, Cultured; Verapamil | 1995 |
Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line.
Topics: Antineoplastic Agents; Azides; Cell Survival; Cyclosporine; Daunorubicin; Drug Interactions; Drug Resistance; Glucose; Humans; Leukemia; Sodium Azide; Tumor Cells, Cultured | 1994 |
Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
Topics: 2,4-Dinitrophenol; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport, Active; Cell Line; Cell Membrane; Daunorubicin; Digitonin; Humans; Hydrogen-Ion Concentration; Kinetics; Mice; Sodium Azide; Subcellular Fractions; Uncoupling Agents; Vincristine | 1996 |
Calcein is excreted from the intestinal mucosal cell membrane by the active transport system.
Topics: Animals; Azides; Biological Transport, Active; Caco-2 Cells; Calcium Channel Blockers; Cell Membrane; Cell Membrane Permeability; Daunorubicin; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Intestinal Mucosa; Jejunum; Probenecid; Rats; Renal Agents; Sodium Azide; Sodium Fluoride; Verapamil | 1997 |
Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
Topics: Antibiotics, Antineoplastic; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blood Cells; Cell Nucleus; Colchicine; Cytochalasin B; Cytoplasm; Daunorubicin; Deoxyglucose; Fluorescent Antibody Technique, Indirect; Humans; Leukemia, Myeloid, Acute; Microscopy, Confocal; Monensin; Nigericin; Sodium Azide; Temperature; Tumor Cells, Cultured | 1997 |
Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Enzyme Inhibitors; Female; Humans; Iodoacetates; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Sodium Azide; Vault Ribonucleoprotein Particles | 2003 |